Michael Brady Lynch to Lecture on Pradaxa Bleeding at AAJ Annual Convention
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. I am pleased to announce that I will be lecturing on the regulatory history of Pradaxa for the AAJ Pradaxa Litigation Group at the upcoming American Association for Justice’s (AAJ) Annual Convention to be held in Chicago on July 28-31, 2012.
Read MoreConsumer Alert! NuvaRing Birth Control Health Risks
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. In May, new evidence emerged linking the contraceptive device, NuvaRing, to increased risk of blood clots and related health issues. The British Medical Journal (BMJ) published a study that found 6.5 times increased risk of life-threatening blood clots for women who
Read MoreGlaxoSmithKline Fined Billions Over Paxil and Wellbrutin
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. Yesterday there was a glimmer of hope from the Justice Department. Drug maker GlaxoSmithKline agreed to an unprecedented settlement with the Justice Department which includes $1 billion in criminal fines and $2 billion in civil fines. GSK targeted the antidepressant Paxil
Read More